Context Therapeutics Inc. (CNTX)
Context Therapeutics Statistics
Share Statistics
Context Therapeutics has 89.7M shares outstanding. The number of shares has increased by 19.61% in one year.
| 89.7M |
| 19.61% |
| 19.61% |
| 90.44% |
| n/a |
| 343 |
| 0.19% |
Short Selling Information
The latest short interest is 2.27M, so 2.54% of the outstanding shares have been sold short.
| 2.27M |
| 2.54% |
| 3.08% |
| 32.8 |
Valuation Ratios
The PE ratio is -2.3 and the forward PE ratio is -1.65. Context Therapeutics's PEG ratio is 0.03.
| -2.3 |
| -1.65 |
| 0 |
| 0.8 |
| 0.64 |
| -2.09 |
| 0.03 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Context Therapeutics.
| n/a |
| n/a |
| n/a |
| n/a |
Financial Position
The company has a current ratio of 35.62, with a Debt / Equity ratio of 0.
| 35.62 |
| 35.62 |
| 0 |
| -0.01 |
| -0.01 |
| 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| n/a |
| n/a |
| n/a |
| n/a |
| $-2,227,092 |
| 12 |
| 0 |
| n/a |
Taxes
| n/a |
| 0% |
Stock Price Statistics
The stock price has increased by -61.99% in the last 52 weeks. The beta is 1.86, so Context Therapeutics's price volatility has been higher than the market average.
| 1.86 |
| -61.99% |
| 0.74 |
| 1.31 |
| 46.58 |
| 179,257 |
Balance Sheet
The company has 94.43M in cash and 219.38K in debt, giving a net cash position of 94.21M.
| 94.43M |
| 219.38K |
| 94.21M |
| -94.78M |
| 92.97M |
| 90.83M |
Cash Flow
In the last 12 months, operating cash flow was -14.56M and capital expenditures -14.76M, giving a free cash flow of -29.31M.
| -14.56M |
| -14.76M |
| -29.31M |
| -0.5 |
Margins
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
Dividends & Yields
CNTX does not appear to pay any dividends at this time.
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
Analyst Forecast
The average price target for CNTX is $5, which is 669.2% higher than the current price. The consensus rating is "Buy".
| $5 |
| 669.2% |
| Buy |
| 4 |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| n/a |
| n/a |
| n/a |
| n/a |
Scores
| 16 |
| 2 |